-
Mashup Score: 2
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 25, 2022.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 3
A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, IV remdesivir and prolonged oral steroids. Twenty days of nirmatrelv …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
Successful treatment of #prolonged, #severe #COVID-19 #lower #respiratory #tract #disease in a B-cell ALL patient with an #extended #course of #remdesivir and #nirmatrelvir / #ritonavir https://t.co/oP9p0Dpbwu https://t.co/NHVQgadnqR
-
-
Mashup Score: 8Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial - Nature Communications - 1 year(s) ago
Many survivors of COVID-19 experience persistent symptoms, continuing beyond three months from the onset of infection. In this study, authors investigate the effect of remdesivir on recovery and long-COVID-19 symptoms, as well as quality of life and other symptom outcomes, in the 1-year follow-up of a randomised trial.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
Effect of remdesivir post-hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial @NevalainenOlli @KariTikkinen @helsinkiuni @HelsinkiUniMed #SolidarityFinland #COVID #LongCovid #EBM #remdesivir https://t.co/EJZDdP9qYj https://t.co/55HUFo3Tx6
-
-
Mashup Score: 15Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial - Nature Communications - 1 year(s) ago
Many survivors of COVID-19 experience persistent symptoms, continuing beyond three months from the onset of infection. In this study, authors investigate the effect of remdesivir on recovery and long-COVID-19 symptoms, as well as quality of life and other symptom outcomes, in the 1-year follow-up of a randomised trial.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
Effect of remdesivir post-hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial @NevalainenOlli @KariTikkinen @helsinkiuni @HelsinkiUniMed #SolidarityFinland #COVID #LongCovid #EBM #remdesivir https://t.co/EJZDdORPzJ https://t.co/ZXIiAI3wLG
-
-
Mashup Score: 0
Alloimmune responses in kidney transplant (KT) patients previously hospitalized with COVID-19 are understudied. We analyzed a cohort of 112 kidney transplant recipients who were hospitalized following a positive SARS-CoV-2 test result during the first 20 months of the COVID-19 pandemic. We found a cumulative incidence of 17% for the development of new donor-specific antibodies (DSA) or increased…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
#COVID19 vaccination and #Remdesivir are associated with protection from new or increased levels of #DSA among #KidneyTransplant recipients hospitalized with COVID19 https://t.co/RtwavNjZxS https://t.co/xAAtqaTK9c
-
-
Mashup Score: 2When and which patients should receive remdesivir? - 2 year(s) ago
Despite 2 years having passed since the start of the COVID-19 pandemic, there is still intense debate about the best therapeutic strategy for patients with COVID-19. Multiple randomised studies have evaluated the efficacy of different antiviral,1,2 anti-inflammatory, and antithrombotic treatments. However, results have been disparate and difficult to interpret at times due to conflicting results;…
Source: The LancetCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Debate about when & which patients should receive #remdesivir or co-adjuvant treatments is set to continue. Learn more in a Comment by @c_garciavidal & Maurizio Sanguinetti. https://t.co/shnBgwbAyt
-
-
Mashup Score: 44
Remdesivir has no significant effect on patients with COVID-19 who are already being ventilated. Among other hospitalised patients, it has a small effect against death or progression to ventilation (or both).
Source: The LancetCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New—#Remdesivir & 3 other drugs for hospitalised patients with COVID-19: final results of @WHO Solidarity randomised trial & updated meta-analyses. https://t.co/0vXlIA0aLD https://t.co/bqYN5SjrTn
-
-
Mashup Score: 0FDA Expands Approval of Remdesivir for Pediatric Patients - 2 year(s) ago
The US FDA expanded the approval of remdesivir for pediatric patients 28 days of age and older weighing at least 3 kg (~7 lbs).
Categories: Latest Headlines, PulmonologyTweet-
Remdesivir (Veklury) now approved for infants as young as 28 days old https://t.co/DR2YXQMXIC #RTmagazine #COVID #remdesivir #pediatrics
-
-
Mashup Score: 0FDA approves first treatment for young children with COVID-19 - 2 year(s) ago
The FDA has approved Veklury for pediatric patients aged 28 days and older who are hospitalized for COVID-19 or have mild to moderate COVID-19 and are at risk for severe disease.It is the first COVID-19 treatment approved in the U.S. for young children, according to the FDA.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
The @US_FDA has approved #Veklury for pediatric patients aged 28 days and older who are hospitalized for #COVID19 or have mild to moderate COVID-19 and are at risk for severe disease. #pediatrics #remdesivir #highrisk https://t.co/hRcOtLC7oK
-
-
Mashup Score: 1
The supplemental new drug application is expanded to include the youngest COVID-19 patients.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
“This approval means that #remdesivir can potentially provide meaningful clinical improvement, by reducing disease progression and helping children recover from COVID-19 more quickly.” #FDA https://t.co/ifdFr5rPX8
-
It takes 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 18, 2022. https://t.co/aKEKZateB3 #AI #Hottopics #rsv #covid19 #remdesivir #ventilation #botm #contacttracing #students #university #therapyanimals #infectionrisks #healthcare